Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal disease

Deighan, C., Caslake, M., McConnell, M., Boulton-Jones, J. and Packard, C. (2001) Comparative effects of cerivastatin and fenofibrate on the atherogenic lipoprotein phenotype in proteinuric renal disease. Journal of the American Society of Nephrology, 12(2), pp. 341-348.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Caslake, Professor Muriel
Authors: Deighan, C., Caslake, M., McConnell, M., Boulton-Jones, J., and Packard, C.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
College of Medical Veterinary and Life Sciences
Journal Name:Journal of the American Society of Nephrology

University Staff: Request a correction | Enlighten Editors: Update this record